PFBT
RLAY icon

Parkside Financial Bank & Trust’s Relay Therapeutics RLAY Stock Holding History

Parkside Financial Bank & Trust’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.41K Hold
129
– – ﹤0.01% 2121
2026
Q1 		$1.28K Hold
129
– – ﹤0.01% 2262
2025
Q4 		$1.09K Hold
129
– – ﹤0.01% 2315
2025
Q3 		$674 Buy
+129
New +$492 ﹤0.01% 2424
2025
Q2 		– Sell
-125
Closed -$327 – 2960
2025
Q1 		$327 Buy
+125
New +$490 ﹤0.01% 2612

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Parkside Financial Bank & Trust's RLAY Position: Q2 2026 in Review

Parkside Financial Bank & Trust held its Relay Therapeutics (RLAY) position steady in Q2 2026 at 129 shares worth $2.41K. The position accounts for ﹤0.01% of the portfolio, ranked #2121.

Parkside Financial Bank & Trust first reported a position in RLAY in Q1 2025 and has held it in 5 quarters since. 259 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Parkside Financial Bank & Trust held 129 shares of Relay Therapeutics worth $2.41K as of Q2 2026.
  • Parkside Financial Bank & Trust left its Relay Therapeutics share count unchanged in Q2 2026.
  • Relay Therapeutics made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #2121 holding.
  • Parkside Financial Bank & Trust first reported a position in Relay Therapeutics in Q1 2025 and has held it in 5 quarters since.
  • 259 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.